These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26820968)

  • 1. High Frequency of Pulmonary Hypertension-Causing Gene Mutation in Chinese Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Xi Q; Liu Z; Zhao Z; Luo Q; Huang Z
    PLoS One; 2016; 11(1):e0147396. PubMed ID: 26820968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States.
    Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T
    Curr Med Res Opin; 2011 Sep; 27(9):1763-8. PubMed ID: 21793646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelets are highly activated in patients of chronic thromboembolic pulmonary hypertension.
    Yaoita N; Shirakawa R; Fukumoto Y; Sugimura K; Miyata S; Miura Y; Nochioka K; Miura M; Tatebe S; Aoki T; Yamamoto S; Satoh K; Kimura T; Shimokawa H; Horiuchi H
    Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2486-94. PubMed ID: 25169936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the Novel Variants in Patients With Chronic Thromboembolic Pulmonary Hypertension.
    Yaoita N; Satoh K; Satoh T; Shimizu T; Saito S; Sugimura K; Tatebe S; Yamamoto S; Aoki T; Kikuchi N; Kurosawa R; Miyata S; Nagasaki M; Yasuda J; Shimokawa H
    J Am Heart Assoc; 2020 Nov; 9(21):e015902. PubMed ID: 33103541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence variants in BMPR2 and genes involved in the serotonin and nitric oxide pathways in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: relation to clinical parameters and comparison with left heart disease.
    Ulrich S; Szamalek-Hoegel J; Hersberger M; Fischler M; Garcia JS; Huber LC; Grünig E; Janssen B; Speich R
    Respiration; 2010; 79(4):279-87. PubMed ID: 19844076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Prevalence of CTEPH after pulmonary embolism.
    Guérin L; Couturaud F; Parent F; Revel MP; Gillaizeau F; Planquette B; Pontal D; Guégan M; Simonneau G; Meyer G; Sanchez O
    Thromb Haemost; 2014 Sep; 112(3):598-605. PubMed ID: 24898545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMPR2 germline mutation in chronic thromboembolic pulmonary hypertension.
    Feng YX; Liu D; Sun ML; Jiang X; Sun N; Mao YM; Jing ZC
    Lung; 2014 Aug; 192(4):625-7. PubMed ID: 24728306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red cell distribution width: a new predictor for chronic thromboembolic pulmonary hypertension after pulmonary embolism.
    Abul Y; Ozsu S; Korkmaz A; Bulbul Y; Orem A; Ozlu T
    Chron Respir Dis; 2014 May; 11(2):73-81. PubMed ID: 24595892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inefficient exercise gas exchange identifies pulmonary hypertension in chronic thromboembolic obstruction following pulmonary embolism.
    McCabe C; Deboeck G; Harvey I; Ross RM; Gopalan D; Screaton N; Pepke-Zaba J
    Thromb Res; 2013; 132(6):659-65. PubMed ID: 24157082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic profile in endothelial cells of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension.
    Smolders VFED; Rodríguez C; Blanco I; Szulcek R; Timens W; Piccari L; Roger Y; Hu X; Morén C; Bonjoch C; Sebastián L; Castellà M; Osorio J; Peinado VI; Bogaard HJ; Quax PHA; Cascante M; Barberà JA; Tura-Ceide O
    Sci Rep; 2022 Feb; 12(1):2283. PubMed ID: 35145193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and survival of adult Swedish PAH and CTEPH patients 2000-2014.
    Rådegran G; Kjellström B; Ekmehag B; Larsen F; Rundqvist B; Blomquist SB; Gustafsson C; Hesselstrand R; Karlsson M; Kornhall B; Nisell M; Persson L; Ryftenius H; Selin M; Ullman B; Wall K; Wikström G; Willehadson M; Jansson K;
    Scand Cardiovasc J; 2016 Aug; 50(4):243-50. PubMed ID: 27146648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension-A Genetic Study.
    Eichstaedt CA; Verweyen J; Halank M; Benjamin N; Fischer C; Mayer E; Guth S; Wiedenroth CB; Egenlauf B; Harutyunova S; Xanthouli P; Marra AM; Wilkens H; Ewert R; Hinderhofer K; Grünig E
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Thromboembolic Pulmonary Hypertension Cases Cluster in Families.
    Dodson MW; Allen-Brady K; Brown LM; Elliott CG; Cannon-Albright LA
    Chest; 2019 Feb; 155(2):384-390. PubMed ID: 30732691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of pulmonary hypertension.
    Best DH; Austin ED; Chung WK; Elliott CG
    Curr Opin Cardiol; 2014 Nov; 29(6):520-7. PubMed ID: 25159282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary and acquired thrombotic risk factors for chronic thromboembolic pulmonary hypertension.
    Wong CL; Szydlo R; Gibbs S; Laffan M
    Blood Coagul Fibrinolysis; 2010 Apr; 21(3):201-6. PubMed ID: 20182352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertension.
    Eichstaedt CA; Saßmannshausen Z; Shaukat M; Cao D; Xanthouli P; Gall H; Sommer N; Ghofrani HA; Seyfarth HJ; Lerche M; Halank M; Kleymann J; Benjamin N; Harutyunova S; Egenlauf B; Milger K; Rosenkranz S; Ewert R; Klose H; Hoeper MM; Olsson KM; Lankeit M; Lange TJ; Hinderhofer K; Grünig E
    Respir Res; 2022 Mar; 23(1):74. PubMed ID: 35346192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Research in Chronic Thromboembolic Pulmonary Hypertension.
    Opitz I; Kirschner MB
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30759794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Riociguat: a novel therapeutic option for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Mielniczuk LM; Swiston JR; Mehta S
    Can J Cardiol; 2014 Oct; 30(10):1233-40. PubMed ID: 25154043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lowest VE/VCO₂ ratio best identifies chronic thromboembolic pulmonary hypertension.
    Xi Q; Zhao Z; Liu Z; Ma X; Luo Q; Liu W
    Thromb Res; 2014 Dec; 134(6):1208-13. PubMed ID: 25283585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The oxygen kinetic effect of inhaled iloprost in pulmonary artery hypertension and chronic thromboembolic pulmonary hypertension].
    Cui N; Yang YH; Xie WM; Ma ZH; Luo L; Wang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Jul; 32(7):522-6. PubMed ID: 19954007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.